| AUGUST, 2013 Gene-Related Patents Issued - Full patent: http://patft.uspto.gov/netahtml/PTO/srchnum.htm | ||||
| CHEMISTRY: ANALYTICAL AND IMMUNOLOGICAL TESTING | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,513,028 | Use of MLN51 gene and protein | Creagene Inc. | 20-Aug-13 | Korea |
| 8,518,669 | Recombinant expression plasmid vector and recombinant strain to be used in producing oxalate decarboxylase, and method of producing recombinant oxalate decarboxylase | Amano Enzyme Inc. | 27-Aug-13 | Japan |
| 8,507,248 | Genetically engineered biological indicator | American Sterilizer Company | 13-Aug-13 | United States |
| 8,507,217 | Ethanol yield and reduction of biomass accumulation in the recombinant strain of Saccharomyces cerevisiae overexpressing atpase | Archer Daniels Midland Company | 13-Aug-13 | United States |
| 8,501,447 | Perhydrolase variant providing improved specific activity | E. I. du Pont de Nemours and Company | 6-Aug-13 | United States |
| 8,507,225 | Oligonucleotides for genotyping thymidylate synthase gene | F. Hoffmann-La Roche AG | 13-Aug-13 | Switzerland |
| 8,518,699 | Methods for genetic diversification in gene conversion active cells | GSF-Forschungszentrum fur Umwelt und Gesundheit, GmbH | 27-Aug-13 | Germany |
| 8,512,994 | Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA | Institut Pasteur | 20-Aug-13 | France |
| 8,512,993 | Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA | Institut Pasteur | 20-Aug-13 | France |
| 8,507,220 | Tobacco BY2 cells containing a tomato mosaic virus vector for protein production | Japan Science and Technology Agency | 13-Aug-13 | Japan |
| 8,501,431 | Method for screening for compounds selectively interacting with RAD9 | Magnachem International Laboratories, Inc. | 6-Aug-13 | United States |
| 8,501,413 | Methods and compositions for detecting a drug resistant EGFR mutant | Memorial-Sloan Kettering Cancer Center | 6-Aug-13 | United States |
| 8,518,650 | Biomarkers for prostate cancer and methods using the same | Metabolon, Inc. | 27-Aug-13 | United States |
| 8,518,687 | Cellulose hydrolase and gene thereof | National Pingtung University of Science and Technology | 27-Aug-13 | Taiwan |
| 8,512,944 | PRMT1 for target genes of cancer therapy and diagnosis | OncoTherapy Science, Inc. | 20-Aug-13 | Japan |
| 8,501,464 | Lentiviral vectors carrying synthetic bi-directional promoters and uses thereof | Ospedale San Raffaele S.r.l | 6-Aug-13 | Italy |
| 8,501,433 | Solvent for chromogenic substrate solution | Pierce Biotechnology, Inc. | 6-Aug-13 | United States |
| 8,512,948 | Compositions and methods for detecting mutations in JAK2 nucleic acid | Quest Diagnostics Investments Incorporated | 20-Aug-13 | United States |
| 8,513,000 | High-throughput cell transfection device and methods of using thereof | Rational Biotechnology, Inc. | 20-Aug-13 | United States |
| 8,507,265 | High-throughput cell transfection device and methods of using thereof | Rational Biotechnology, Inc. | 13-Aug-13 | United States |
| 8,518,701 | Methods and materials for producing transgenic artiodactyls | Recombinetics, Inc. | 27-Aug-13 | United States |
| 8,518,644 | Method of judging inflammatory disease by using single nucleotide polymorphism | Riken | 27-Aug-13 | Japan |
| 8,501,442 | Determination of 5-ASA efficacy in CRC prevention and/or treatment by gene expression analysis | Sofar SpA | 6-Aug-13 | Italy |
| 8,512,999 | Production of oil in microorganisms | Solazyme, Inc. | 20-Aug-13 | United States |
| 8,507,273 | Gene encoding a multidrug resistance human P-glycoprotein homologue on chromosome 7p15-21 and uses thereof | The Brigham and Women's Hospital, Inc. | 13-Aug-13 | United States |
| 8,507,245 | Site-directed pegylation of arginases and the use thereof as anti-cancer and anti-viral agents | The Hong Kong Polytechnic University | 13-Aug-13 | Hong Kong |
| 8,501,404 | Gnaq mutations in melanoma | The Regents of the University of California | 6-Aug-13 | United States |
| 8,513,005 | DNA immunogenic composition comprising a full-length modified poxvirus L1R gene fused to a tPA leader sequence | The United States of America as Represented by the Secretary of the Army | 20-Aug-13 | United States |
| 8,518,685 | Engineered nitrile hydratase-producing bacterium with amidase gene knocked-out, the construction and the use thereof | Tsinghua University | 27-Aug-13 | China P Rep |
| 8,507,250 | Methods and genetically engineered micro-organisms for the combined production of PDO, BDO and PHP by fermentation | Tsinghua University | 13-Aug-13 | China P Rep |
| 8,518,657 | Method of prognosing and diagnosing hereditary spastic paraplegia, mutant nucleic acid molecules and polypeptides | Universite de Montreal | 27-Aug-13 | Canada |
| 8,518,698 | Method of promoting apoptosis of glioblastoma tumor cells | University of Central Florida Research Foundation, Inc. | 27-Aug-13 | United States |
| 8,501,401 | Steroidogenesis modified cells and methods for screening for endocrine disrupting chemicals | University of Saskatchewan | 6-Aug-13 | Canada |
| 8,512,957 | Toxicity typing using liver stem cells | Vistagen Therapeutics, Inc. | 20-Aug-13 | United States |
| 8,507,247 | Influenza A virus with attenuating mutations in NS2 protein | Wisconsin Alumni Research Foundation | 13-Aug-13 | United States |
| DATA PROCESSING | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,515,680 | Analysis of transcriptomic data using similarity based modeling | Venture Gain L.L.C. | 20-Aug-13 | United States |
| DRUG | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,512,710 | Class of therapeutic protein based molecules | Ansun Biopharma, Inc. | 20-Aug-13 | United States |
| 8,507,445 | Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer | Board of Regents, The University of Texas System | 13-Aug-13 | United States |
| 8,518,892 | Methods to treat symptoms of pathophysiology related to body mass | Board of Supervisors of Louisiana State University and Agricultural Mechanical College | 27-Aug-13 | United States |
| 8,507,553 | Benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereof | Daewoong Pharmaceutical Co., Ltd. | 13-Aug-13 | Korea |
| 8,501,706 | Duplex oligonucleotide complexes and methods for gene silencing by RNA interference | Dharmacon, Inc. | 6-Aug-13 | United States |
| 8,513,207 | Extended dicer substrate agents and methods for the specific inhibition of gene expression | Dicerna Pharmaceuticals, Inc. | 20-Aug-13 | United States |
| 8,506,948 | UCB-MSCs comprising a tumor suppressor gene reduce the size of an IL-8 or GRO-.alpha.expressing tumor | Medipost Co., Ltd | 13-Aug-13 | Korea |
| 8,518,907 | RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA) | Merck Sharp & Dohme Corp. | 27-Aug-13 | United States |
| 8,507,458 | System for delivering nucleic acids for suppressing target gene expression by utilizing endogenous chylomicron | National University Corporation Tokyo Medical and Dental University | 13-Aug-13 | Japan |
| 8,518,392 | Promoter-regulated differentiation-dependent self-deleting cassette | Regeneron Pharmaceuticals, Inc. | 27-Aug-13 | United States |
| 8,513,233 | Pyrimidinyl-propionic acid derivatives and their use as PPAR agonists | Shanghai Institute of Materia Medica, CAS | 20-Aug-13 | China P Rep |
| 8,512,709 | Modified amyloid .beta. peptide | The Chemo-Sero-Therapeutic Research Institue | 20-Aug-13 | Japan |
| 8,501,812 | Therapeutic methods for type I diabetes | University of Massachusetts | 6-Aug-13 | United States |
| 8,507,433 | Cardioprotective effects of GHRH agonists | University of Miami | 13-Aug-13 | United States |
| 8,518,391 | Monocytes as a gene delivery vector for secreted proteins to treat Alzheimer'S disease | University of South Florida | 27-Aug-13 | United States |
| MULTICELLULAR LIVING ORGANISMS | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,507,755 | Methods for altering the reactivity of plant cell walls | Bayer Cropscience N.V. | 13-Aug-13 | Belgium |
| 8,513,485 | Non human transgenic mammal comprising a transgene comprising a nucleotide sequence encoding a ribosomal protein fused to a peptide tag | Envoy Therapeutics, Inc. | 20-Aug-13 | United States |
| 8,519,225 | Identification and use of target genes for control of plant parasitic nematodes | Monsanto Technology LLC | 27-Aug-13 | United States |
| 8,513,491 | Dehydrin genes and promoters from coffee | Nestec S.A. | 20-Aug-13 | Switzerland |
| 8,502,018 | Methods of modifying eukaryotic cells | Regeneron Pharmaceuticals, Inc. | 6-Aug-13 | United States |
| 8,507,754 | Engineering lipids in vegetative tissues of plants | University of North Texas | 13-Aug-13 | United States |
| NATURAL RESINS OR DERIVATIVES | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,519,099 | Methods for production of proteins | Life Technologies Corporation | 27-Aug-13 | United States |
| 8,519,097 | Molecules for targeting compounds to various selected organs or tissues | Prosena Technologies B.V. | 27-Aug-13 | Netherlands |
| ORGANIC COMPOUNDS | ||||
| Pat No | Title | Assignee | Date Issued | Country |
| 8,507,663 | Compositions and methods for inhibiting expression of CD274/PD-L1 gene | Alnylam Pharmaceuticals, Inc. | 13-Aug-13 | United States |
| 8,513,401 | Double stranded nucleic acid targeting low copy promoter-specific RNA | City of Hope | 20-Aug-13 | United States |
| 8,501,924 | Nucleophosmin protein (NPM) mutants, corresponding gene sequences and uses thereof | Falini; Brunangelo | 6-Aug-13 | Italy |
| 8,513,403 | Modified siRNA molecules and uses thereof | Protiva Biotherapeutics, Inc. | 20-Aug-13 | United States |



